Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance

BACKGROUND: Deleterious variants in the tumour suppressor BRCA1 are known to cause hereditary breast and ovarian cancer syndrome (HBOC). Missense variants in BRCA1 pose a challenge in clinical care, as their effect on protein functionality often remains unknown. Many of the pathogenic missense varia...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Genomics
Auteurs principaux: Langerud, Jonas, Jarhelle, Elisabeth, Van Ghelue, Marijke, Ariansen, Sarah Louise, Iversen, Nina
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Primary Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247502/
https://ncbi.nlm.nih.gov/pubmed/30458859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40246-018-0183-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires